KEY FEATURES
| Full Name | Cluster Of Differentiation 3d |
|---|---|
| Synonym | CD3-DELTA; T3D; T-Dell Surface Glycoprotein CD3 Delta Chain; T-cell receptor T3 delta chain |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CD3d in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD3d. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD3d and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD3d, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD3d. You can calculate the concentration of Human CD3d in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD3d ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.01 | 2.46 | 7.15 | 1.04 | 2.31 | 6.89 |
| Standard deviation | 0.06 | 0.1 | 0.33 | 0.07 | 0.14 | 0.21 |
| CV(%) | 5.88 | 4.24 | 4.61 | 6.77 | 5.86 | 3.03 |
RECOVERY
The recovery of Human CD3d spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-103 | 98 |
| EDTA plasma (n=8) | 86-97 | 91 |
| Cell culture media (n=8) | 89-101 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD3d in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CD3d ELISA Kits
| CD3G ELISA Kit | publications with CD3d and CD3G |
| CD3E ELISA Kit | publications with CD3d and CD3E |
| LCK ELISA Kit | publications with CD3d and LCK |
| ZAP70 ELISA Kit | publications with CD3d and ZAP70 |
| CD8A ELISA Kit | publications with CD3d and CD8A |
| CD247 ELISA Kit | publications with CD3d and CD247 |
| ITK ELISA Kit | publications with CD3d and ITK |
| FYN ELISA Kit | publications with CD3d and FYN |
| CD8B ELISA Kit | publications with CD3d and CD8B |
Pathways associated with CD3d ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| CXCR4-mediated Signaling Events Pathway | CXCR4-mediated Signaling Events Pathway |
| Chagas Disease (American Trypanosomiasis) Pathway | Chagas Disease (American Trypanosomiasis) Pathway |
| Costimulation By The CD28 Family Pathway | Costimulation By The CD28 Family Pathway |
| Downstream TCR Signaling Pathway | Downstream TCR Signaling Pathway |
| Downstream Signaling In Naive CD8+ T Cells Pathway | Downstream Signaling In Naive CD8+ T Cells Pathway |
| Generation Of Second Messenger Molecules Pathway | Generation Of Second Messenger Molecules Pathway |
| HTLV-I Infection Pathway | HTLV-I Infection Pathway |
Diseases associated with CD3d ELISA Kit
| Lymphoma | publications with CD3d and Lymphoma |
| Inflammation | publications with CD3d and Inflammation |
| Severe Combined Immunodeficiency | publications with CD3d and Severe Combined Immunodeficiency |
| Breast Neoplasms | publications with CD3d and Breast Neoplasms |
| Necrosis | publications with CD3d and Necrosis |
| Anemia | publications with CD3d and Anemia |
| Uterine Neoplasms | publications with CD3d and Uterine Neoplasms |
| Myocardial Infarction | publications with CD3d and Myocardial Infarction |
| Lung Neoplasms | publications with CD3d and Lung Neoplasms |
Organs/Tissues associated with CD3d ELISA Kit
| Blood | publications with CD3d and Blood |
| Thymus | publications with CD3d and Thymus |
| Heart | publications with CD3d and Heart |
| Intestine | publications with CD3d and Intestine |
| Bone Marrow | publications with CD3d and Bone Marrow |
| Spleen | publications with CD3d and Spleen |
| Lymph Node | publications with CD3d and Lymph Node |
| Lung | publications with CD3d and Lung |
| Muscle | publications with CD3d and Muscle |
| Eye | publications with CD3d and Eye |